Recombinant interferon-α therapy in patients with follicular lymphoma
✍ Scribed by Howard Ozer; Peter H. Wiernik; Francis Giles; Craig Tendler
- Book ID
- 101229711
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 118 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
BACKGROUND.
Advanced stage, follicular, non-Hodgkin's lymphoma (NHL) has no
📜 SIMILAR VOLUMES
Two patients with chronic-phase chronic granulocytic leukemia initially responded to recombinant interferon a-2a (rlFN-a-2a) but relapsed as a result of development of hightiter neutralizing antibodies to rlFN-a-Sa. Both patients were subsequently treated with natural leukocyte IFN-(Y (IFN-a-n3), an
## Abstract The follicular non‐Hodgkin's lymphomas (NHL) have been among those tumors demonstrated to show frequent responses to alpha interferon in phase I and II clinical trials. In addition, there are data suggesting that alpha interferon demonstrates synergistic antitumor activity with alkylati